Intrinsiqq
Pharming Group N.V. ADR logo

Pharming Group N.V. ADR Financials

PHAR

Compare

All currency values in $ millions unless otherwise noted

Scroll

Income Statement
TTM
DEC 2025
DEC 2024
DEC 2023
DEC 2022
DEC 2021
Revenues
Revenue$366$376$297$245$206$204
Cost of Revenue$49$46$35$25$18$22
Gross Profit$317$331$262$220$188$182
Total Operating Expenses$305$310$265$242$178$163
Operating Income$12$21-$4-$22$10$20
Non-Operating
Net Interest Expense-$15-$11-$9-$6-$5-$6
Income Tax Expense$7$10$3-$1$1$7
Net Income
Net Income$9$3-$12-$11$14$16
Per Share Data
Revenue Per Share$4.92$5.28$4.32$3.73$3.16$3.18
EPS (Basic)$0.12$0.04-$0.16-$0.16$0.21$0.24
EPS (Diluted)$0.12$0.04-$0.16-$0.16$0.19$0.22
Shares Outstanding74.5M71.3M68.8M65.7M65.1M64.2M
Dividends Per Share$0.00$0.00$0.00$0.00$0.00$0.00

Pharming Group N.V. ADR (PHAR) financials: revenue, profit and margins

Pharming Group N.V. ADR (PHAR) generated about $366 million in revenue and $9 million in net income (a 2.5% net margin) over the trailing twelve months, growing at roughly 16.5% a year. Figures are from company filings; this is analysis, not investment advice.

Frequently asked

What is Pharming Group N.V. ADR's (PHAR) revenue?+

Pharming Group N.V. ADR generated about $366 million in revenue over the trailing twelve months. Revenue has grown at roughly 16.5% a year over the past five years. Revenue is the top line, before any costs; what matters for value is how much of it survives to free cash flow. The full income statement, balance sheet and cash-flow statement are on this tab.

Is Pharming Group N.V. ADR profitable?+

Yes, Pharming Group N.V. ADR reported about $9 million in net income over the trailing twelve months, a net profit margin of roughly 2.5%. Net income is the bottom line after all costs, interest and taxes. Compare it to free cash flow on this tab, since reported profit and actual cash generated can diverge.

What are Pharming Group N.V. ADR's profit margins?+

Pharming Group N.V. ADR runs a gross margin of about 86.5%, an operating margin of about 3.4%, a net margin of about 2.5%. Margins show how much of each sales dollar a company keeps at each stage. Stable or rising margins usually signal pricing power and cost discipline; falling margins are worth investigating. See the multi-year trend on this tab.

How fast is Pharming Group N.V. ADR growing?+

Pharming Group N.V. ADR's revenue has compounded at roughly 16.5% a year over the past five years. Growth only creates value when it is profitable and cash-generative, so read this rate alongside PHAR's margins and free cash flow. This is analysis from company filings, not investment advice.

How the market compares: How many US companies are profitable

Peers

Biotechnology · Pick stocks to compare with PHAR

CompareIntrinsic value
M12.XETRM1 Kliniken AG
€18.62-4.51%91
CARA.XSTOCarasent AB
€2.14-0.70%54
PPGN.XSWXPolyPeptide Group AG
No recent price30
PAX.XSTOPaxman AB
€6.00+2.92%39
MLECMoolec Science SA
No recent price10
SKAN.XSWXSKAN Group AG
No recent price33
CANTA.XSTOCantargia AB
€0.08+0.24%54
EUZ.XETREckert & Ziegler SE
€14.48-1.83%74

Spot a number that looks wrong?

Download this analysis as a PDF (Pro)

Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

5 of 5 free stocks used today

Keep analysing PHAR

A free account gives you 10 stocks a day, a watchlist and price alerts.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

MarketsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.